FERRARI DANIELA

Radoszkiewicz, K., Bzinkowska, A., Sypecka, M., Sulejczak, D., Ferrari, D., Gelati, M., et al. (2025). Unraveling the impact of human cerebrospinal fluid on human neural stem cell fate. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 13 [10.3389/fcell.2025.1527557]. Detail

Giovenale, A., Turco, E., Ferrone, I., Giacometti, C., Tomaselli, S., Vulcano, E., et al. (2025). Generation and characterization of the CSSi021-A (15665) human induced pluripotent stem cell line from a Smith-Magenis syndrome patient with a heterozygous RAI1 mutation. STEM CELL RESEARCH, 86(August 2025) [10.1016/j.scr.2025.103726]. Detail

Perciballi, E., Bovio, F., Ferro, S., Forcella, M., Rosati, J., Carletti, R., et al. (2025). Mitochondrial and energy metabolism dysfunctions are hallmarks of TDP-43G376D fibroblasts from members of an Amyotrophic Lateral Sclerosis family. CELL DEATH & DISEASE, 16(1) [10.1038/s41419-025-07584-2]. Detail

Vulcano, E., Lombardi, I., Rasà, D., Ferrero, C., Perciballi, E., Ferro, S., et al. (2024). Preliminary data of ICV delivery of human Neural Stem Cells in a mouse model of Amyotrophic Lateral Sclerosis. Intervento presentato a: Congresso Aging Project 2024 – Aging in progress: dalla ricerca di base all’applicazione sul territorio, Novara, Italia. Detail

Mazzini, L., De Marchi, F., Buzanska, L., Follenzi, A., Glover, J., Gelati, M., et al. (2024). Current status and new avenues of stem cell-based preclinical and therapeutic approaches in amyotrophic lateral sclerosis. EXPERT OPINION ON BIOLOGICAL THERAPY, 24(9), 933-954 [10.1080/14712598.2024.2392307]. Detail